ASBrS 2023 Exact Sciences Product Theater Registration |
Please join us for our Product Theater on Wednesday, April 26 at 7pm - 8:30pm ET in the Hynes Convention Center (Room 306).
Title: Current Controversies in the Care of Patients with Hormone Receptor-Positive, HER2-Negative Early Breast Cancer in the Era of Genomics
Speakers:
Tari King, MD
Chief, Breast Surgery, Dana Farber/Brigham and Women's Hospital
Chief, Breast Surgery, Dana Farber/Brigham and Women's Hospital
Christy Russell, MD & Jennifer Racz, MD, Exact Sciences
Objectives:
- Review the wealth of data on the Oncotype DX Breast Recurrence Score® test in pre- and postmenopausal patients
- Interrogate current controversies at the intersection of genomic testing with patient menopausal status, local regional recurrence, and clinicopathologic features
- Discuss how guidelines have been informed by TAILORx and RxPONDER trials
- Interrogate current controversies at the intersection of genomic testing with patient menopausal status, local regional recurrence, and clinicopathologic features
- Discuss how guidelines have been informed by TAILORx and RxPONDER trials